Drawing for BI BIOLOGICAL INDUSTRIES CULTURE OF EXCELLENCE

USPTO serial 87452078

BI BIOLOGICAL INDUSTRIES CULTURE OF EXCELLENCE

Reviewed by CopyMark Law Group

Reg. 5436543Status 710
Filing date
Status date
Registration date
Apr 3, 2018
Examiner
WATTS-FITZGERALD, CAITLIN C
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with BI BIOLOGICAL INDUSTRIES CULTURE OF EXCELLENCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alexander Lazouski

ALEXANDER LAZOUSKI LAZOUSKI IP LLCSUITE 1, 14726 BOWFIN TER.,LAKEWOOD RANCH, FL 34202UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry and science; Mixtures of chemicals and microorganisms for sterilizing compost for use in agriculture; Chemical substances, chemical materials and chemical preparations and natural elements all the foregoing being chemicals for use in industry and science; Reagents for scientific or medical research use; Reagents for scientific or medical research use, namely, reagents for use in immunoserology; Diagnostic preparations other than for medical or veterinary purposes; Stem cells for research and scientific purposes; Anti-freezing preparations; Freezing agents for use in freezing biological specimens, namely, cryogenic preparations in solid, liquid or gas state for use in chilling and freezing; Reagents for research purposes, namely, blood grouping reagents other than for medical use; Cell culture media for scientific and research use; Cell culture media for scientific and research use, namely, blood cell culture media for scientific use; biological activators for plants; Pharmaceuticals, medical and veterinary preparations, namely, biological preparation for use in cell cultures other than for medical or veterinary useSECTION 8 - CANCELLEDSep 5, 2011
005Medical and veterinary preparations and articles, namely, bacterial and bacteriological preparations for medical or veterinary purposes; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes, Diagnostic agents, preparations and substances for medical purposes; Pharmaceuticals and natural remedies, namely, natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; Bacteriological culture mediums; serums, namely, medicated hair serums; Pharmaceutical preparations, namely, medicated hair serums; Pharmaceutical preparations for human use, namely, human vaccine preparations; Pharmaceutical preparations for medical purposes, namely, diagnostic preparations for medical purposes; Pharmaceutical preparations for activating cellular function; Cellular function activating agents for medical purposes; Cellulose esters for pharmaceutical purposes; Medicines for intestinal disorders; Pharmaceutical drugs, namely, drug delivery agents in the form of powders, tablets and capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drugs for medical purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Live organs and tissues for surgical purpose; Stem cells for medical purposes; Clinical medical reagents; Cultures of microorganism for medical use; Medical products to support the growth of stem cells, namely, cytostatics for pharmaceutical purposes; Surgical implants grown from stem cells in the nature of surgical implants comprised of living tissues; Medical diagnostic reagents; Reargents for blood grouping in the nature of reagents for medical use; Blood components, namely, platelet rich blood plasma and stem cells for medical use; Blood plasma; Blood substitutes for human useSECTION 8 - CANCELLEDSep 5, 2011
041Education services, namely, conducting programs and courses in the field of science and medicine; publication services, namely, publishing of journals, books and handbooks; publication of scientific research, namely, publishing and issuing scientific papers in relation to medical technology; Publication of the results of clinical trials for pharmaceutical preparations; Arranging and conducting educational conferences, courses, trainings, seminars in the field of science and medicineSECTION 8 - CANCELLEDSep 5, 2011
042Scientific and technological services, namely, scientific research and analysis in the field of medicine; research and development services in connection with medicine; Industrial analysis and research services in the field of medicine; scientific and biological services, namely, biological cloning services; natural science services, namely, consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; medical laboratory services; medical and pharmacological research and development services; biological analysis; biological research; clinical research and medical research, namely, basic and clinical research in the field of respiratory science and medicine; biological development, namely, custom design and development of safe chemical and biological agent simulants for use in air quality measurement; Consultancy relating to pharmaceutical research and development, namely, technical consulting in the field of pharmaceutical studies; Research in the field of stem cells; Research and development of vaccines and medicines; Development of pharmaceutical preparations and medicines; Analysis of human serum for medical research; Pharmaceutical drug development services; Provision of information and data relating to medical and veterinary research and development; Testing, authentication and quality control for others in the field of medical and pharmaceutical research; Advisory services relating to material testing, namely, materials testing and analysing; Analysis of human tissues for medical research; Scientific research and development services relating to the isolation and cultivation of human tissues and cellsSECTION 8 - CANCELLEDSep 5, 2011
044Medical services; stem cell storage in the nature of stem cell bank services; Medical services relating to the removal, treatment and processing of stem cells; Medical analysis services in the nature of analysis of human serum for medical treatment; Medical analysis services in the nature of analysis of human tissues for medical treatmentSECTION 8 - CANCELLEDSep 5, 2011

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 25, 2024C8..CANCELLED SEC. 8 (6-YR)—
Apr 3, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 3, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 16, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 16, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 27, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 7, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 5, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 5, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 1, 2017ALIEASSIGNED TO LIE—
Nov 20, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 7, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 7, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 7, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 7, 2017DOCKASSIGNED TO EXAMINER—
May 23, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
May 22, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 19, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance